Xylem (NYSE:XYL) CAO Geri-Michelle Mcshane Sells 4,269 Shares

Key Points

• Xylem CAO Geri-Michelle Mcshane sold 4,269 shares on May 7 at an average price of $117.46, totaling about $501,437. After the sale, she held 3,605 shares, a 54.22% reduction in her position.
• Xylem reported stronger-than-expected quarterly results, with EPS of $1.12 versus the $1.09 consensus and revenue of $2.13 billion, slightly above estimates. Revenue rose 2.7% year over year.
• The company continued returning capital to shareholders by increasing its quarterly dividend to $0.43 from $0.40 and authorizing a $1.5 billion share repurchase plan. Analysts currently rate the stock a “Moderate Buy” on average with a target price of $152.77.

Xylem Inc. (NYSE:XYL - Get Free Report) CAO Geri-Michelle Mcshane sold 4,269 shares of the firm's stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the sale, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. The trade was a 54.22% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Xylem Stock Performance

NYSE XYL traded down $1.88 during mid-day trading on Friday, reaching $113.76. 2,184,291 shares of the stock were exchanged, compared to its average volume of 2,050,303. The company has a market capitalization of $27.04 billion, a P/E ratio of 28.30, a P/E/G ratio of 1.69 and a beta of 1.08. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. The business's 50 day moving average is $122.63 and its 200-day moving average is $134.10. Xylem Inc. has a 1 year low of $113.45 and a 1 year high of $154.27.

Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating analysts' consensus estimates of $1.09 by $0.03. The company had revenue of $2.13 billion during the quarter, compared to analysts' expectations of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The firm's revenue for the quarter was up 2.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.03 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, equities research analysts forecast that Xylem Inc. will post 5.51 EPS for the current fiscal year.

Xylem declared that its Board of Directors has initiated a share repurchase plan on Wednesday, February 25th that allows the company to buyback $1.50 billion in outstanding shares. This buyback authorization allows the industrial products company to buy up to 4.8% of its stock through open market purchases. Stock buyback plans are often a sign that the company's board of directors believes its stock is undervalued.

Xylem Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 24th. Shareholders of record on Tuesday, February 24th were given a dividend of $0.43 per share. This is an increase from Xylem's previous quarterly dividend of $0.40. This represents a $1.72 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date was Tuesday, February 24th. Xylem's dividend payout ratio (DPR) is currently 42.79%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. Royal Bank Of Canada decreased their price objective on shares of Xylem from $176.00 to $162.00 and set an "outperform" rating on the stock in a report on Wednesday, February 11th. JPMorgan Chase & Co. lowered their price objective on Xylem from $170.00 to $160.00 and set an "overweight" rating on the stock in a report on Thursday, April 16th. William Blair initiated coverage on Xylem in a report on Monday, January 26th. They set an "outperform" rating for the company. Stifel Nicolaus lowered their price target on Xylem from $163.00 to $159.00 and set a "buy" rating on the stock in a research note on Wednesday, April 29th. Finally, Weiss Ratings downgraded Xylem from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Monday, April 6th. Seven analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. According to MarketBeat.com, Xylem presently has an average rating of "Moderate Buy" and an average target price of $152.77.

Institutional Investors Weigh In On Xylem

A number of large investors have recently made changes to their positions in XYL. Knuff & Co LLC purchased a new stake in Xylem in the 3rd quarter valued at $27,000. Board of the Pension Protection Fund acquired a new position in shares of Xylem during the 4th quarter valued at about $27,000. Commonwealth Retirement Investments LLC acquired a new stake in Xylem during the fourth quarter worth about $27,000. Wexford Capital LP purchased a new position in Xylem during the third quarter worth about $27,000. Finally, First Horizon Corp purchased a new position in Xylem during the third quarter worth about $30,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

About Xylem

Xylem Inc NYSE: XYL is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.